Immediate Impact
20 by Nobel laureates 35 from Science/Nature 58 standout
Citing Papers
Engineering protein-based therapeutics through structural and chemical design
2023 Standout
Targeting IL-6 trans-signalling: past, present and future prospects
2023 Standout
Works of Marcos E. Milla being referenced
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism
2021
Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Marcos E. Milla | 1540 | 622 | 279 | 395 | 59 | 2.6k | |
| Patric Turowski | 2145 | 560 | 251 | 365 | 44 | 3.8k | |
| Dana L. Johnson | 1531 | 639 | 149 | 256 | 53 | 3.1k | |
| Joerg Kallen | 1832 | 725 | 314 | 174 | 58 | 3.5k | |
| Jürgen Hoppe | 2650 | 212 | 227 | 327 | 98 | 3.7k | |
| V. Kinzel | 2578 | 424 | 252 | 180 | 125 | 3.4k | |
| Ronald E. Diehl | 2747 | 603 | 233 | 479 | 32 | 4.1k | |
| Kathleen A. Gallo | 2180 | 410 | 295 | 170 | 69 | 3.2k | |
| Jeffrey R. Peterson | 2843 | 676 | 329 | 271 | 71 | 4.4k | |
| J E Casnellie | 2168 | 391 | 124 | 315 | 42 | 3.1k | |
| Christoph Schächtele | 2399 | 617 | 243 | 315 | 77 | 4.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...